Journal of the Korean Medical Association (대한의사협회지)

Korean Medical Association (대한의사협회)
권호 표지
DOI QR코드

DOI QR Code

Recent updates on treatment for pediatric migraine

소아청소년 편두통 치료의 최신지견

  • Lee, Kon-Hee (Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University School of Medicine)
  • 이건희 (한림대학교 의과대학 강남성심병원 소아청소년과)
  • Received : 2016.12.18
  • Accepted : 2016.12.31
  • Published : 2017.02.20
⟨ Previous Next ⟩

Abstract

Pediatric migraine is a disorder that significantly interferes with the everyday life and school life of approximately 8% of children and adolescents in Korea. Recently, studies on migraine have been carried out very rapidly, many drugs have been developed, and acute-phase and preventive treatments for migraine have been evaluated. Therefore, it is necessary to understand the diagnostic criteria and degree of impairment in pediatric migraine and to become familiar with up-to-date treatment methods in children. Research into the use of botulinum toxin or calcitonin gene-related peptide antagonists to treat adult migraine headaches is progressing, and we expect these therapies to be applicable to pediatric patients soon. Many students in our country are suffering from migraines in their daily life. Therefore, we need to acquire the relevant knowledge and identify practical treatment methods for pediatric migraine in children and adolescents in order to reduce their pain.

Keywords

References

  1. Rho YI, Chung HJ, Lee KH, Eun BL, Eun SH, Nam SO, Kim WS, Kim YO, Park HJ, Kim HS. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache 2012;52:592-599. https://doi.org/10.1111/j.1526-4610.2011.02001.x
  2. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808. https://doi.org/10.1177/0333102413485658
  3. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia 2007;27:394-402. https://doi.org/10.1111/j.1468-2982.2007.01303.x
  4. Chakravarty A, Mukherjee A, Roy D. Trigger factors in childhood migraine: a clinic-based study from eastern India. J Headache Pain 2009;10:375-380. https://doi.org/10.1007/s10194-009-0147-x
  5. Neut D, Fily A, Cuvellier JC, Vallee L. The prevalence of triggers in paediatric migraine: a questionnaire study in 102 children and adolescents. J Headache Pain 2012;13:61-65. https://doi.org/10.1007/s10194-011-0397-2
  6. Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003;28:9-15. https://doi.org/10.1016/S0887-8994(02)00466-6
  7. Chung BY, Hong YL. Comparisons of Stressor and coping style between headache-suffering children and headache-free children. Child Health Nurs Res 2000;6:354-361.
  8. Yoon JM, Lee HR, Lee KH. Characteristics of sleep disorders in childhood and adolescence. J Korean Child Neurol Soc 2007;15:185-191.
  9. Rocha-Filho PA, Santos PV. Headaches, quality of life, and academic performance in schoolchildren and adolescents. Headache 2014;54:1194-1202. https://doi.org/10.1111/head.12394
  10. Hong EY, Choi KY, Kim SK, Jung AY, Lee KH. Clinical characteristics and diagnoses for pediatric headache in the emergency department. Korean J Headache 2013;14:1-5.
  11. Alfonzo M, Chen L. Acute migraine management in children. Pediatr Emerg Care 2015;31:722-727. https://doi.org/10.1097/PEC.0000000000000590
  12. Nye BL, Ward TN. Clinic and emergency room evaluation and testing of headache. Headache 2015;55:1301-1308. https://doi.org/10.1111/head.12648
  13. Richer L, Craig W, Rowe B. Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine. Headache 2014;54:1496-1505. https://doi.org/10.1111/head.12443
  14. Richer L, Billinghurst L, Linsdell MA, Russell K, Vandermeer B, Crumley ET, Durec T, Klassen TP, Hartling L. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;4:CD005220.
  15. Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache 2016;56:49-70. https://doi.org/10.1111/head.12746
  16. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004;43:256-262. https://doi.org/10.1016/S0196-0644(03)00716-9
  17. Gelfand AA, Goadsby PJ. Treatment of pediatric migraine in the emergency room. Pediatr Neurol 2012;47:233-241. https://doi.org/10.1016/j.pediatrneurol.2012.06.001
  18. Kabbouche M. Pediatric inpatient headache therapy: what is available. Headache 2015;55:1426-1429. https://doi.org/10.1111/head.12701
  19. Sheridan DC, Meckler GD. Inpatient pediatric migraine treatment: does choice of abortive therapy affect length of stay? J Pediatr 2016;179:211-215. https://doi.org/10.1016/j.jpeds.2016.08.050
  20. Tajti J, Szok D, Csati A, Vecsei L. Prophylactic drug treatment of migraine in children and adolescents: an update. Curr Pain Headache Rep 2016;20:1. https://doi.org/10.1007/s11916-015-0536-6
  21. Kacperski J, Hershey AD. Preventive drugs in childhood and adolescent migraine. Curr Pain Headache Rep 2014;18:422. https://doi.org/10.1007/s11916-014-0422-7
  22. Hickman C, Lewis KS, Little R, Rastogi RG, Yonker M. Prevention for pediatric and adolescent migraine. Headache 2015;55:1371-1381. https://doi.org/10.1111/head.12699
  23. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40:539-549. https://doi.org/10.1046/j.1526-4610.2000.00085.x
  24. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004;44:230-237. https://doi.org/10.1111/j.1526-4610.2004.04052.x
  25. Kim H, Byun SH, Kim JS, Lim BC, Chae JH, Choi J, Kim KJ, Hwang YS, Hwang H. Comparison of flunarizine and topiramate for the prophylaxis of pediatric migraines. Eur J Paediatr Neurol 2013;17:45-49. https://doi.org/10.1016/j.ejpn.2012.10.001
  26. Abbaskhanian A, Sadeghi HR, Erfani A, Rezai MS. Effective dose of topiramate in pediatric migraine prophylaxis. J Pediatr Neurosci 2012;7:171-174. https://doi.org/10.4103/1817-1745.106470
  27. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921-936. https://doi.org/10.1111/j.1526-4610.2010.01678.x

Cited by

  1. Recent advances in pediatric headaches vol.60, pp.2, 2017, https://doi.org/10.5124/jkma.2017.60.2.109
  2. Effects of Occipital Nerve Block in Pediatric Patients with Occipital Region Headache vol.29, pp.4, 2017, https://doi.org/10.26815/acn.2021.00507